Imaging Lymphoid Cell Death In Vivo During Polymicrobial Sepsis*
暂无分享,去创建一个
W. Chao | Howard H. Chen | D. Sosnovik | Larry L. Wang | Yan Feng | Lin Zou | Ganqiong Xu | Dan Li | Chan Chen
[1] L. Josephson,et al. Cytoprotective nanoparticles by conjugation of a polyhis tagged annexin V to a nanoparticle drug. , 2015, Nanoscale.
[2] C. Benoist,et al. Genomic responses to inflammation in mouse models mimic humans: We concur, apples to oranges comparisons won’t do , 2014, Proceedings of the National Academy of Sciences.
[3] T. Miyakawa,et al. Reply to Warren et al. and Shay et al.: Commonalities across species do exist and are potentially important , 2014, Proceedings of the National Academy of Sciences.
[4] I. Cinel,et al. Sepsis and Acute Kidney Injury. , 2014, Turkish journal of anaesthesiology and reanimation.
[5] R. Hotchkiss,et al. Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality , 2014, Shock.
[6] Keizo Takao,et al. Genomic responses in mouse models greatly mimic human inflammatory diseases , 2014, Proceedings of the National Academy of Sciences.
[7] J. Thurman,et al. Complement Factor B Is the Downstream Effector of TLRs and Plays an Important Role in a Mouse Model of Severe Sepsis , 2013, The Journal of Immunology.
[8] J. Bertin,et al. Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL* , 2013, The Journal of Biological Chemistry.
[9] J. Vincent,et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. , 2013, JAMA.
[10] T. Miyakawa,et al. Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .
[11] R. Gamelli,et al. Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.
[12] Yan Li,et al. Nonhematopoietic Toll-Like Receptor 2 Contributes to Neutrophil and Cardiac Function Impairment During Polymicrobial Sepsis , 2011, Shock.
[13] Yan Li,et al. Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.
[14] Shi-Xian Deng,et al. The Ngal Reporter Mouse Detects the Response of the Kidney to Injury in Real Time , 2010, Nature Medicine.
[15] P. Devarajan,et al. Review: Neutrophil gelatinase‐associated lipocalin: A troponin‐like biomarker for human acute kidney injury , 2010, Nephrology.
[16] M. Scherrer-Crosbie,et al. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis* , 2010, Critical care medicine.
[17] G. Dai,et al. Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure , 2009, Circulation. Cardiovascular imaging.
[18] R. Star,et al. Animal models of sepsis and sepsis-induced kidney injury. , 2009, The Journal of clinical investigation.
[19] C. Coopersmith,et al. The sepsis seesaw: tilting toward immunosuppression , 2009, Nature Medicine.
[20] K. Honda,et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity , 2008, Proceedings of the National Academy of Sciences.
[21] Haitao Wen,et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events , 2008, The Journal of experimental medicine.
[22] Y. Ni,et al. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent. , 2008, Bioorganic & medicinal chemistry letters.
[23] C. Chung,et al. The apoptotic pathway as a therapeutic target in sepsis. , 2007, Current drug targets.
[24] J. Siddiqui,et al. Mechanisms of Mortality in Early and Late Sepsis , 2006, Infection and Immunity.
[25] C. Reutelingsperger,et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] L. Doughty,et al. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. , 2005, Blood.
[27] Ralph Weissleder,et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle , 2005, Magnetic resonance in medicine.
[28] F. Hoebers,et al. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] H. Bartelink,et al. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. , 2004, International journal of radiation oncology, biology, physics.
[30] A. Schroit,et al. Aminophospholipid asymmetry: A matter of life and death. , 2003, Annual review of physiology.
[31] P. Wischmeyer,et al. Distance of Cecum Ligated Influences Mortality, Tumor Necrosis Factor-Alpha and Interleukin-6 Expression following Cecal Ligation and Puncture in the Rat , 2003, European Surgical Research.
[32] I. Chaudry,et al. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity , 2003, Journal of leukocyte biology.
[33] D. Angus,et al. Unraveling severe sepsis: why did OPTIMIST fail and what's next? , 2003, JAMA.
[34] P. Thimister,et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[36] Roland Hustinx,et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[38] R. Hotchkiss,et al. Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.
[39] C. Reutelingsperger,et al. Visualisation of cell death , 2000, The Lancet.
[40] R. Hotchkiss,et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.
[41] P. Doevendans,et al. Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.
[42] S. Korsmeyer,et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Hotchkiss,et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.
[44] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.
[45] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[46] N. Goldstein. Mice are not men! , 1994, Hawaii medical journal.
[47] D. Rittirsch,et al. Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.
[48] R. Flavell,et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. , 2007, American journal of physiology. Heart and circulatory physiology.
[49] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[50] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.